NASDAQ · Healthcare · Biotechnology
Parabilis Medicines, Inc.
PBLS
Fog Pharmaceuticals, Inc. CEO Mathai Mammen · Market cap $94.3M.
$28.80
+2.44 · +9.26%
52w hi $34.4752w lo $24.51
Off 52w high 22.9%
86
STRONG
Current InsiderScore
Corp · 90d
6
6 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
2 strong · 1 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 15 | Alan Sebulsky | Buy | 4,065 | $27.10 | +$110K | 48 | |
| Jun 15 | Alan Sebulsky | Buy | 5,000 | $26.00 | +$130K | 48 | |
| Jun 12 | Alan Sebulsky | Buy | 8,435 | $27.67 | +$233K | 55 | |
| Jun 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,460,397 | $20.00 | +$29.21M | 86 | |
| Jun 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 19,728,353 | $20.00 | +$394.57M | 86 | |
| Jun 11 | Alan Sebulsky | Buy | 12,500 | $20.00 | +$250K | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun